Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
201.48
-1.76 (-0.87%)
At close: Jul 2, 2024, 4:00 PM
202.00
+0.52 (0.26%)
After-hours: Jul 2, 2024, 7:20 PM EDT
CRL Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for CRL stock have an average target of 257.55, with a low estimate of 205 and a high estimate of 290. The average target predicts an increase of 27.83% from the current stock price of 201.48.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Buy | 4 | 5 | 5 | 5 | 4 | 4 |
| Hold | 4 | 5 | 5 | 5 | 4 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 13 | 13 | 11 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 28, 2024 |
| Mizuho | Mizuho | Hold Initiates $235 | Hold | Initiates | $235 | +16.64% | Jun 7, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $290 | Strong Buy | Initiates | $290 | +43.93% | Jun 6, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $260 → $228 | Hold | Maintains | $260 → $228 | +13.16% | May 13, 2024 |
| Baird | Baird | Buy Maintains $282 → $270 | Buy | Maintains | $282 → $270 | +34.01% | May 10, 2024 |
Financial Forecast
Revenue This Year
4.26B
from 4.13B
Increased by 3.21%
Revenue Next Year
4.59B
from 4.26B
Increased by 7.63%
EPS This Year
11.13
from 9.22
Increased by 20.68%
EPS Next Year
12.50
from 11.13
Increased by 12.39%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.5B | 4.9B | 5.3B | 5.3B | 5.7B |
| Avg | 4.3B | 4.6B | 4.9B | 5.1B | 5.5B |
| Low | 4.1B | 4.4B | 4.7B | 4.9B | 5.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.0% | 15.2% | 15.3% | 7.2% | 12.3% |
| Avg | 3.2% | 7.6% | 7.7% | 3.0% | 7.3% |
| Low | -0.9% | 2.6% | 1.4% | -0.2% | 3.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.83 | 13.58 | 15.51 | 15.91 | 17.46 |
| Avg | 11.13 | 12.50 | 14.01 | 15.29 | 16.78 |
| Low | 10.38 | 11.64 | 13.08 | 14.83 | 16.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 28.3% | 22.0% | 24.0% | 13.6% | 14.2% |
| Avg | 20.7% | 12.4% | 12.0% | 9.2% | 9.7% |
| Low | 12.6% | 4.6% | 4.6% | 5.9% | 6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.